I just can't get over what the upgrade entails for V2. This whole full-featured, SaaS sales tool can be scaled in a very big way, across all platforms and social media. The whole investment community will soon see, we're fortunate before this up lists and big money rolls in from institutions and other brokerages who are unable to get into OTCs.